Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature

Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature

Saved in:

Bibliographic Details
Main Authors:	Patricia Lopez, Sven Kohler, Seema Dimri
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Transplantation
Online Access:	http://dx.doi.org/10.1155/2014/305931
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
by: Goran B. Klintmalm, et al.
Published: (2014-01-01)

A Decade of Experience Using mTor Inhibitors in Liver Transplantation
by: Jeffrey Campsen, et al.
Published: (2011-01-01)

mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin
by: Kewei Zheng, et al.
Published: (2024-12-01)

Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
by: Gianluigi Zaza, et al.
Published: (2013-01-01)

Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease
by: L. Friedrich, et al.
Published: (2012-01-01)

Everolimus in Heart Transplantation: An Update
by: Stephan W. Hirt, et al.
Published: (2013-01-01)

Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma
by: J. Martin-Liberal, et al.
Published: (2014-01-01)

Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer
by: Jingyang Li, et al.
Published: (2025-02-01)

mTOR Inhibition: From Aging to Autism and Beyond
by: Matt Kaeberlein
Published: (2013-01-01)

The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway
by: Danilo Figueiredo Soave, et al.
Published: (2016-01-01)

GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling
by: Fan Zhang, et al.
Published: (2021-01-01)

Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition
by: Aimin Yang, et al.
Published: (2015-01-01)

FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway
by: Wen Meng, et al.
Published: (2020-01-01)

The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas
by: Elias A. El Habr, et al.
Published: (2012-01-01)

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment
by: Jiarui Lv, et al.
Published: (2025-01-01)

Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
by: Serena Patel, et al.
Published: (2018-01-01)

Incidence, prevalence, and predictors of osteoporotic fracture in adult lung transplant recipients
by: Elisabeth Ng, et al.
Published: (2025-02-01)

Candida dubliniensis breast implant infection in a lung transplant recipient
by: Ashley Barnes, MD, et al.
Published: (2025-02-01)

The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4+ T Cell Subsets
by: Peng Wang, et al.
Published: (2020-01-01)

Beneficial Effects of Resveratrol-Mediated Inhibition of the mTOR Pathway in Spinal Cord Injury
by: Jingying Zhou, et al.
Published: (2018-01-01)

Involvement of Mechanistic Target of Rapamycin (mTOR) in Valine Orexigenic Effects in Rainbow Trout
by: Sara Comesaña, et al.
Published: (2022-01-01)

NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target
by: Hongbo Huang, et al.
Published: (2022-01-01)

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
by: B. J. Edwards, et al.
Published: (2011-01-01)

Preoperative Cardiac Variables of Diastolic Dysfunction and Clinical Outcomes in Lung Transplant Recipients
by: Ajay Yadlapati, et al.
Published: (2013-01-01)

Antibody-Mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient
by: Ashwini Arjuna, et al.
Published: (2021-01-01)

Growth Hormone Increases BDNF and mTOR Expression in Specific Brain Regions after Photothrombotic Stroke in Mice
by: Sonia Sanchez-Bezanilla, et al.
Published: (2022-01-01)

Alcohol Inhibits Odontogenic Differentiation of Human Dental Pulp Cells by Activating mTOR Signaling
by: Wei Qin, et al.
Published: (2017-01-01)

The Roles of Autophagy, Mitophagy, and the Akt/mTOR Pathway in the Pathogenesis of Chronic Rhinosinusitis with Nasal Polyps
by: Chen Wang, et al.
Published: (2022-01-01)

Inhibition of the mTOR Pathway Exerts Cardioprotective Effects Partly through Autophagy in CLP Rats
by: Wen Han, et al.
Published: (2018-01-01)

Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL)
by: Fateme Arjmand, et al.
Published: (2024-07-01)

Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient
by: Kelly E. Schoeppler, et al.
Published: (2015-01-01)

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
by: Heinrike Wilkens, et al.
Published: (2016-01-01)

Donor-derived cell-free DNA for detection of acute rejection in lung transplant recipients
by: Gökce Yavuz, et al.
Published: (2025-01-01)

Dynamic 19F-MRI of pulmonary ventilation in lung transplant recipients with and without chronic lung allograft dysfunction
by: Mary A. Neal, PhD, et al.
Published: (2025-02-01)

Health-related Quality of Life and Exercise Capacity in Double Lung Transplant Recipients With Baseline Lung Allograft Dysfunction
by: Alisha Rullay, BSc, et al.
Published: (2025-02-01)

Proton Pump Inhibitor-Induced Galactorrhea in a Kidney Transplant Recipient: A Friend or Foe?
by: Marios Prikis, et al.
Published: (2020-01-01)

The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
by: Juan Du, et al.
Published: (2016-01-01)

PDK1/mTOR Signaling in Myeloid Cells Differentially Regulates the Early and Late Stages of Sepsis
by: Juan Du, et al.
Published: (2020-01-01)

Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway
by: Yanni Pan, et al.
Published: (2025-01-01)

TSC complex decrease the expression of mTOR by regulated miR-199b-3p
by: Na Zhao, et al.
Published: (2025-01-01)